ABSTRACT Background: There is conflicting epidemiological evidence concerning an increase in risk of non-Hodgkin's lymphoma (NHL) associated with elevated blood levels of persistent organochlorine (OC) pesticides and polychlorobiphenyls (PCBs). Methods: We measured the concentration of 17 OC pesticides, including hexachlorobenzene (HCB), four lindane isomers (a-, b-, c-and d-hexachlorocyclohexane (HCH)), two chlordane species (heptachlor and oxychlordane), four cyclodiene insecticides (aldrin, dieldrin, endrin and mirex), six dichloro-diphenyl-trichloroethane (DDT) isomers and nine PCB congeners (PCBs 28, 52, 101, 118, 138, 153, 170, 180 and 194) in plasma samples of 377 subjects, including 174 NHL cases and 203 controls from France, Germany and Spain. The risk of NHL and its major subtypes associated with increasing blood levels of OC pesticides and PCBs was calculated using unconditional logistic regression. Results: Risk of NHL, diffuse large B cell lymphoma (DLBCL) and chronic lymphatic leukaemia (CLL) did not increase with plasma levels of HCB, b-HCH, p,p9-dichlorodiphenyl-dichloroethylene (DDE), or total and individual PCBs or their functional groups, in the overall study population. Substantial heterogeneity in DLBCL risk associated with immunotoxic PCBs (p = 0.03) existed between the Spanish subgroup (odds ratio (OR) for immunotoxic PCB plasma level above the median vs below the median was 0.7, 95% CI 0.3 to 1.6) and the French and German subgroups combined (OR 3.2, 95% CI 0.9 to 11.5). Conclusion: We did not find evidence of an association between NHL risk and plasma level of OC pesticides and PCBs.
The incidence of non-Hodgkin's lymphoma (NHL) has been increasing in most parts of the world 1 at an annual rate of 1-5% each year in both genders, 2 3 although more recent figures suggest the increasing trend has slowed in the USA and northern Europe. 3 4 Interest in research on lymphoma risk associated with the body burden of organochlorine (OC) pesticides and polychlorobiphenyls (PCBs) is based on several reports of an excess risk in relation to elevated levels of OC pesticides and PCBs in blood or adipose tissue. [5] [6] [7] [8] The limited size of previous studies has not allowed analysis by lymphoma subtype. In addition, results have been inconsistent, particularly for dichloro-diphenyl-trichloroethane (DDT), although early reports in the literature suggested an association between DDT and an increase in risk of leukaemia and lymphoma among farmers. [9] [10] [11] [12] [13] [14] However, most recent studies tend to rule out an association with DDT while implicating other OC pesticides such as lindane. 15 16 OC pesticides and PCBs are extremely persistent in the environment and, once absorbed in the workplace or through diet and the environment, in living organisms. Neurotoxic, nephrotoxic, immunotoxic and endocrine-disrupting effects to the reproductive organs as well as the thyroid have been described for OC pesticides such as bhexachlorocyclohexane (b-HCH), 17 hexachlorobenzene (HCB) 18 and DDT, [19] [20] [21] in laboratory animals as well as humans. Effects on the immune system, reproductive system, nervous system, endocrine system and other health effects have also been described for PCBs. 22 The toxicological properties of PCBs vary with the number and position of the chlorine atoms, as substitution in the ortho position hinders the rotation of the two rings. PCBs without ortho substitution are generally referred to as coplanar and all others as noncoplanar. Pseudo-oestrogen properties have been described for the low chlorinated PCB28, PCB52 and PCB153, 23 24 whereas high chlorinated PCBs, including PCB170, PCB180 and PCB194, are antioestrogenic. 23 PCBs 101, 153, 180 and 194 are capable of inducing phenobarbital (PB), while mixed PB-and 3-methyl colanthrene (MC)-inducers include PCBs 118, 138 and 170. 23 Several common PCBs, including PCB138, PCB153 and PCB180 share immunotoxic properties, 25 26 and PCBs 101 and 138 are considered to be BRCA1 inhibitors. 27 Such different toxicological properties have seldom been explored in relation to lymphoma risk.
Because of the potential for human carcinogenicity, the WHO International Agency for Research on Cancer has classified PCBs as probable human carcinogens (group 2A), while chlordane, DDT, heptachlor, HCB, the HCH isomers and mirex are classified as possible humans carcinogens (group 2B) and aldrin, dieldrin and endrin are not classifiable as to human carcinogenicity (group 3). 28 We explored the potential association between the plasma level of several OC pesticides and PCBs and risk of NHL and major lymphoma subtypes in a subset of cases and controls who participated in the European multicentre case-control study on the aetiology of lymphoma (Epilymph). Novel features in our study include the analysis of major individual lymphomas according to the WHO classification.
France, Germany and Spain, who participated in the Epilymph study, a multicentre European case-control study of environmental exposures and lymphoid neoplasms. The study size was planned balancing statistical power considerations with the available budget. Samples were locally selected at random among participating subjects. The concentrations of 17 OC pesticides, including HCB, four lindane isomers (a-, b-, c-and d-HCH), two chlordane species (heptachlor and oxy-chlordane), four cyclodiene insecticides (aldrin, dieldrin, endrin and mirex), six DDT isomers and nine PCB congeners (PCBs 28, 52, 111, 118, 138, 153, 170, 180 and 194) were measured in the samples. The OC pesticides selected for study include those more frequently reported in the literature. PCB congeners in this study include the seven congeners regulated by the European Community, plus congeners 170 and 194, which are most frequently reported above the detection limit in the literature.
After assessing the correlation between the p,p'-dichlorodiphenyl-dichloroethylene (DDE) serum and plasma concentrations in nine subjects (r = 0.993), plasma was selected as the biological medium of choice to save serum samples for other measurements for which serum was indispensable. The minimum volume required for a reliable assay was determined by correlating the geometric mean of p,p'-DDE concentrations at two plasma volumes, 0.7 and 2.4 ml (r = 0.995). Plasma aliquots were treated with methanol (1 ml) for precipitation of the plasma protein fraction. After a triple extraction with a 1:1 diethyl ether-hexane mix (2.5 ml) in a rotary evaporator, the extracted fraction was concentrated to 1 ml at 35uC under a nitrogen stream. The concentrate was then purified in a 1.8 g 60-100 mesh Florisil (U.S. Silica Company, Berkeley Springs, WV, USA) column (1062.5 cm), conditioned for 16 h at 130uC with 0.5 g anhydrous sodium sulphate for clean-up. Before injecting the sample, columns were conditioned first with 5-6 ml hexane and secondly using 15 ml of a hexane mix with 6% ethyl-ether. The eluate was then concentrated to 0.5-1 ml in a nitrogen stream, and divided into two fractions of equal volume. Fraction 1 was analysed by gas chromatography with an electron capture detector (ECD) to quantify the concentration of individual OC pesticides (a-, b-, c-and d-HCH, o,p-DDT, p,p'-DDT, o,p-DDE, p,p'-DDE, o,p-TDE, p,p'-TDE, heptachlor, oxychlordane, HCB, aldrin and dieldrin) and total PCBs. Fraction 2 was further purified in a silica gel column with a first elution in hexane and a second in benzene. The eluate was concentrated to 0.5 ml under a nitrogen stream and used to measure PCB congeners by gas chromatography with an ECD. A GC 8000 Fisons Instruments (Rodano, Italy) gas-chromatograph was used, equipped with an AS 800 autosampler and double Ni-63 ECD with a 30 m, I.D. 0.25 mm and 0.25 mm film, J&W DB-5MS column, using helium as the carrier and nitrogen as makeup gas, with fluxes of 1.5 and 30 ml/min, respectively. Gas chromatographic conditions were: column temperature between 120uC and 220uC, with a 5uC/min increase; detector 260uC, inlet 150uC; time for the analysis 100 min. The split ratio was 1:25. Individual OC pesticides and PCBs were determined by comparing their retention time with the reference standard. Quantitative analyses were performed using Chrom-Card for Windows (Fisons Instruments) as the software for signal acquisition and integration. The external standard method consisted of comparing the area observed with 1 ml of the standard, containing the chemicals under analysis in solution with 20% diethyl ether/n-hexane, with that obtained with the injection of the same fraction of the sample to be analysed. Limits of detection were as follows: HCB, a-, c-and d- Lipid-adjusted concentrations of OC pesticides and PCBs were expressed as parts per billion (mg/kg). Total serum lipids were extracted with alcohol, and added to the Kunkel reagent containing phenol (Futura System, Rome, Italy). The extinction, directly proportional to the total lipid concentration, was read at l 620 mm by spectrophotometry.
The analyses were conducted for individual OC pesticides and PCBs, as well as for the following functional PCB groups: 1. pseudo-oestrogen PCBs (PCBs28, 52 and 153), 23 25 26 6. BRCA1 inhibitors (PCBs 101 and 138). 27 Total chlordane was also analysed, resulting from summing up the concentrations of the two chlordane species, oxychlordane and heptachlor.
The repeatability of the measurements of the individual OC pesticides and PCBs was assessed by duplicating the analysis in 1 ml plasma aliquots of 81 study subjects, 38 cases and 43 controls, randomly selected. The intra-class correlation coefficient (ICC) was acceptable (>0.500) for p,p'-DDE, b-HCH and PCB153, which had the greatest median concentrations, but it decreased as the median plasma concentration of the individual OC pesticide or PCB decreased. Overall, this would indicate that using a small plasma aliquot for the analysis (1 ml) would provide reliable results for chemicals represented at relatively elevated plasma concentrations, while repeatability in subsequent assays would be unreliable for individual chemicals detected at median concentrations below 0.5 mg/l. However, as cases and controls were analysed in the same run, and therefore the measurement error was random and independent of the case-control status, we also present results for HCB and several individual PCBs most frequently represented in our study population. 
Statistical methods
The risk of NHL and its major subtypes, associated with increasing blood levels of individual OC pesticides and PCBs, was calculated using unconditional logistic regression with SAS (SAS Institute, Cary, NC, USA). Risk for the most prevalent NHL subtypes, namely diffuse large B cell lymphoma (DLBCL) and chronic lymphocytic leukaemia/small lymphocytic lymphoma (CLL/SLL), was also analysed, but the other lymphoma subtypes were represented by too few cases. The analysis was conducted over the total study population, and, for selected PCBs, for the Spanish study group only, which contributed a larger number of study subjects to our study. The analysis was also conducted for the German and French study groups combined because of their small sample size and substantial overlapping in the median and range of plasma PCB levels. For each individual OC pesticide and PCB, we categorised subjects with undetectable values as the reference group when these numbered 25 or more, and calculated the tertiles of the distribution of measurable values among controls. When subjects with undetectable values numbered less than 25, we calculated quartiles over the whole control group, therefore including subjects with undetectable values in the lowest quartile, which served as the reference group. Information on potentially confounding covariates was based on personal interviews using a structured questionnaire.
Covariates to be included in the regression model were selected based on their contribution to reducing the overall deviance of the regression model. Covariates in the final model included age (continuous), gender, education (two categories of years of attending school, whether lower/equal or greater than the median), centre, and the individual OC pesticide or PCB. Results were very similar when residence, whether urban or rural, was also included in the regression model. The odds ratio (OR) was considered statistically significant when the respective 95% confidence interval (CI) did not include unity. To test the significance of a positive dose-response relationship between lymphoma risk and increasing quartile of the blood level of each individual OC pesticide and PCB, we considered all covariates as non-categorical. The ratio between the regression coefficient associated with the exposure variables and its standard error approximates the normal distribution, and it was used as a test for trend (Wald test for trend). 29 The p values refer to the twotail tests.
The competent ethics committee approved the study protocol in each participating centre.
RESULTS
The mean age of study subjects was 56.5 years (standard deviation (SD) 15.7); it was highest in the Spanish subgroup (mean 56.7 years, SD 16.8) Tables 2-4 show results for the individual OC pesticides and PCB congeners and functional groups for NHL, DLBCL and CLL/ SLL. Analyses were also carried out for NHL excluding CLL/SLL, so as to make it comparable with previous NHL definitions, and for B cell NHL, thus excluding T lymphoma. However, results were quite similar, and only those for NHL including CLL/SLL and Tcell lymphomas are reported in the tables.
Only three OC pesticides, namely b-HCH, HCB and p,p'-DDE, were present at detectable levels in enough study subjects to allow a profitable analysis to be conducted. None showed an association with NHL risk, or with DLBCL or CLL/SLL risk (table 2) . Results were similar when the analysis was conducted separately in the Spanish subgroups and in the French and German subgroups combined (not shown in the tables). Total PCBs and individual PCBs as well as functional PCB groups also did not show an association with NHL, DLBCL or CLL/SLL in the overall study population (tables 3-4). However, when we considered the Spanish study group only, the lack of an association was confirmed (immunotoxic PCB plasma level above the median vs below the median: OR 0.7, 95% CI 0.3 to 1.6), while in the German and French groups combined risk of DLBCL associated with immunotoxic PCB plasma levels above the median showed a threefold increase (OR 3.2, 95% CI 0.9 to 11.5), increasing to sixfold (OR 6.1, 95% CI 1.0 to 37.8) in the upper quartile (Wald test for trend 2.02, p = 0.04) (not shown in the tables). Among individual immunotoxic PCBs, the association observed in the German and French groups combined was strongest for congener 138 (above median vs below median levels: OR 13.3, 95% CI 2.6 to 68.1) (not shown in the tables). No such pattern in risk was observed for NHL overall or for CLL/SLL. We assessed heterogeneity between the two study groups in DLBCL risk associated with total PCB and immunotoxic PCB plasma level, under a random effect model. The summary OR was 1.0 (95% CI 0.5 to 2.0) for total PCBs, and 1.4 (95% CI 0.3 to 6.6) for immunotoxic PCBs. A significant heterogeneity in risk between the two groups was calculated for immunotoxic PCBs (Q test 4.62, p = 0.03) but not for total PCBs (Q test 0.52, p = 0.47).
Blood withdrawal was performed before starting chemotherapy for 58% of the Spanish patients (79/137), which allowed exploration of whether results might have been affected by the administration of chemotherapeutic drugs. No substantial difference in the OR point estimate was related to time of blood withdrawal (not shown in the tables).
DISCUSSION
While the manufacture and use of persistent OC pesticides and PCBs has been banned in most industrialised countries, 30 the use of DDT as an anti-malarial agent persists in many developing countries, and environmental PCB emission still occurs mainly as a result of incineration processes. OC pesticides and PCBs are persistent contaminants in the environment as well as in humans, with most human exposure resulting from dietary consumption.
Sufficient evidence of animal carcinogenicity exists for several of the OC pesticides examined in the present study, including DDT derivatives, chlordane, HCB and HCH species.
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Environmental exposure to several OC pesticides and PCBs has been reported to contribute to the increasing risk of lymphomas, 5 7 8 31 32 confirming earlier reports of an increase in lymphatic cancer risk among farmers, which mainly implicated DDT. [9] [10] [11] [12] [13] [14] The mechanism by which some OC pesticides and PCBs might contribute to the aetiology of NHL is unclear, and might vary by specific chemical. Immunotoxicity, enzyme induction, dioxin-like effects and endocrine disrupting effects might be relevant in this regard. An interaction with viruses, such as the Epstein-Barr virus, 5 7 or allergic diseases, such as asthma, 33 has been suggested, but uncertainties persist as negative findings have also been published. 6 12 In our study, NHL risk did not show a consistent increase with plasma levels of the most frequently measured OC pesticides and individual PCBs or the functional PCB groups we constructed or the sum of the nine PCB congeners we tested. However, we found substantial heterogeneity in DLBCL risk associated with the plasma level of immunotoxic PCBs above the median between the Spanish group and the other two study groups combined. A recent nested case-control study, based on incident NHL cases and controls identified among the participants in three large surveys conducted in Norway and in the USA, showed elevated NHL risks associated with increasing body burden of PCB congeners 118, 138 and 153. 34 In contrast to our study, in that prospective study subjects donated a blood sample while in good health at enrolment to the study at various time points between 1972 and 1978, and PCB serum levels were measured in the serum samples of incident NHL cases and the selected controls some time after the end of follow-up for the purposes of that study. In our study, PCB118, alone or together with the other mixed phenobarbital and 3-MC inducers, did not show an association with NHL risk, and immunotoxic PCBs, including congeners 138, 153 and 180, did not show an association in the overall study population or in the major subgroup of Spanish study subjects. The retrospective case-control design limits inference from our results, as possible interference by the disease process and/or chemotherapy among lymphoma patients might depress PCB levels. 35 Approximately half of the Spanish patients underwent blood withdrawal before initiating chemotherapy. Results in the Spanish group did not change after limiting the analysis to these subjects (not shown in the tables). To explore whether any metabolic interference from the elevated plasma level of HCB and p,p'-DDE in the Spanish study group might have generated such a contrasting finding, we re-analysed NHL and DLBCL risk associated with PCB138 and immunotoxic PCBs in the Spanish group after excluding subjects with HCB and p,p'-DDE levels above the median, to make them comparable to the French and German study subjects. Results did not change (not shown in the tables). Also, models were set using the Spanish group including HCB or p,p'-DDE in various categorisations as a covariate to explore whether these OC pesticides affected NHL and DLBCL risk associated with total PCBs, immunotoxic PCBs, and the individual congeners 138 and 153, as well as the interaction between the two OC pesticides and the PCBs. Again, risk associated with PCBs was not affected, and no significant interaction whatsoever was identified (not shown in the tables). Another possible cause of measurement error is the time lag between blood withdrawal and analysis, because of the possible decay of OC and PCB concentrations as well as lipid concentration in the plasma. Although adjustments by storage duration did not affect our results, this is an additional cause of concern in interpreting our findings.
In conclusion, we did not find evidence of a link between OC and PCB body burden and risk of NHL or the major lymphoma subtypes. Further research is warranted to explore reasons for the heterogeneity between findings across centres, including metabolic interference by elevated blood concentrations of competing OCs and other PCBs, interaction with viruses and other pathogens, and genetic polymorphisms. Original article
